Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02979899
Title A RANDOMIZED PHASE 3 TRIAL OF TRC105 AND PAZOPANIB VERSUS PAZOPANIB ALONE IN PATIENTS WITH ADVANCED ANGIOSARCOMA (TAPPAS)
Acronym TAPPAS
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Tracon Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | AUT


No variant requirements are available.